Symptom Burden, Comorbidity and Functional Status of patients with Chronic Kidney Disease Stage 5 managed conservately
Abstract
Objective: To determine the prevalence and severity of symptoms of patients with Chronic Kidney Disease Stage 5 managed conservately, and their association with the comorbidities and functional status.
Methods: A cross-sectional, descriptive, and correlational design was used. Symptom data were collected using the Spanish modified version of Palliative care Outcome Scale-Symptoms Renal. Comorbidity was collected and scored according to the modified Charlson Comorbidity Index. For the evaluation of functional status, the Barthel index was used.
Results: 60 patients were included in this study. More than 50% of patients described weakness, pain, difficulty for sleeping, poor appetite and mouth problems. Diabetes, coronary artery disease, and peripheral vascular disease, and tumor, were the main comorbid conditions of these patients. The mean score of Barthel index was 88±14.2. There was no significant correlation between comorbidities and symptoms (p=0.43). There was a significant correlation between symptoms and functional decline (p=0.001).
Conclusions: Patients with Chronic Kidney Disease Stage 5 experience a high level of symptom burden. Weakness was the most prevalent symptom in this sample population. Symptom burden correlated with functional decline. Further longitudinal studies are needed that analyse the impact of symptoms and their management in this population.
Downloads
References
Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020 Feb 29;395(10225):709–33. Disponible en: https://doi.org/10.1016/S0140-6736(20)30045-3
Gorostidi M, Sánchez-Martínez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamaría R, et al. Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors. Nefrología (English Edition). 2018 Nov 1;38(6):606–15. Disponible en: https://doi.org/10.1016/j.nefroe.2018.04.010
K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J KidneyDis. 2002;39(2 Suppl1):1-266.
Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney international. 2015;88(3):447–59.1. doi:10.1038/ki.2015.110
Murtagh FE, Addington-Hall J, Edmonds P, Donohoe P, Carey I, Jenkins K, et al. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manage. 2010 Sep;40(3):342–52. Disponible en: https://doi.org/10.1016/j.jpainsymman.2010.01.021
Abdel-Kader K, Unruh ML, Weisbord SD. Symp¬tom burden, depression, and quality of life in chro¬nic and end-stage kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2009;4(6):1057–64. Disponible en: https://doi.org/10.2215/CJN.00430109
Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, et al. A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community: A Randomized Controlled Trial. Clin J Am Soc Nephrol. 2011 Jun;6(6):1241–7. Disponible en: https://doi.org/10.2215/CJN.07160810
Steinhauser KE, Christakis NA, Clipp EC, Mc¬Neilly M, McIntyre L, Tulsky JA. Factors consi¬dered important at the end of life by patients, fa¬mily, physicians, and other care providers. JAMA. 2000;284(19):2476–82.
Manns B, Hemmelgarn B, Lillie E et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol 2014; 9: 1813–1821. Disponible en: https://doi.org/10.2215/CJN.01610214
Leiva-Santos JP, Sánchez-Hernández R, García-Llana H, Fernández-Reyes MJ, Heras-Benito M, Molina-Ordas Á, et al. Cuidados de soporte renal y cuidados paliativos renales: revisión y propuesta en terapia renal sustitutiva. Nefrología (Madrid). 2012;32(1):20–7. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S0211-69952012000100005&lng=es&nrm=iso&tlng=es
Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, et al. ANZSN renal supportive care 2013: opinion pieces [corrected]. Nephrology (Carlton). 2013 Jun;18(6):401–54. Disponible en:https://doi.org/10.1111/nep.12065
Gutiérrez Sánchez D, Leiva-Santos JP, Sánchez-Hernández R, Gómez García R. Prevalencia y evaluación de síntomas en enfermedad renal crónica avanzada. Enfermería Nefrológica. 2015 Sep;18(3):228–36. Disponible en: https://doi.org/10.4321/S2254-28842015000300010
Murphy EL, Murtagh FEM, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clinical Practice. 2009;111(1):74-80. Disponible en: https://doi.org/10.1159/000183177
Gutiérrez-Sánchez D, Leiva-Santos JP, Sánchez-Hernández R, Hernández-Marrero D, Cuesta-Vargas AI. Spanish modified version of the palliative care outcome scale-symptoms renal: cross-cultural adaptation and validation. BMC Nephrol. 2016 Nov 18;17(1):180. Disponible en: https://doi.org/10.1186/s12882-016-0402-8
Beddhu S, Bruns FJ, Saul M, et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am JMed 2000;108(8):609–13. Disponible en: https://doi.org/10.1016/S0002-9343(00)00371-5
Mahoney FI, Barthel DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Maryland State Medical Journal. 1965 Feb;14:61–5.
Andreu Periz L, Andreu-Periz L, Puig Llobet M, Puig-Llobet M, Cases Amenós A, Cases-Amenós A. Grado de dependencia de las personas sometidas a hemodiálisis en Cataluña y evolución de su mortalidad. Nefrología. 2012 Sep 1;32(5):613–21. Disponible en: https://doi.org/10.3265/Nefrologia.pre2012.Jun.11460
Cook WL, Jassal SV. Functional dependencies among the elderly on hemodialysis. Kidney International. 2008 Jun 1;73(11):1289–95. Disponible en: https://doi.org/10.1038/ki.2008.62
Murtagh FEM, Addington-Hall JM, Edmonds PM, Donohoe P, Carey I, Jenkins K, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007 Dec;10(6):1266–76. Disponible en: https://doi.org/10.1089/jpm.2007.0017
Gutiérrez Sánchez D, Leiva-Santos JP, López M, José M, Vargas C, I A. Perfil sintomático de los pacientes con Enfermedad Renal Crónica Estadio 4 y 5. Enfermería Nefrológica. 2017 Sep;20(3):259–66. Disponible en: https://doi.org/10.4321/s2254-28842017000300010
Gutiérrez Sánchez D, Leiva-Santos JP, Cuesta-Vargas AI. Symptom Burden Clustering in Chronic Kidney Disease Stage 5. Clin Nurs Res. 2017 Nov 1;1054773817740671. Disponible en: https://doi.org/10.1177/1054773817740671
Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. ACKD2007;14(1):82-99. Disponible en: https://doi.org/10.1053/j.ackd.2006.10.001
Almutary H, Douglas C, Bonner A. Multidimensional symptom clusters: an exploratory factor analysis in advanced chronic kidney disease. J Adv Nurs. 2016 Oct;72(10):2389–400. Disponible en: https://doi.org/10.1053/j.ackd.2006.10.001
Davison SN, Koncicki H, Brennan F. Pain in chronic kidney disease: a scoping review. Semin Dial. 2014 Mar;27(2):188–204. Disponible en: https://doi.org/10.1111/sdi.12196
Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. JPSM. 2010 Mar;39(3):477–85. Disponible en: https://doi.org/10.1016/j.jpainsymman.2009.08.008
Weiner DE, Seliger SL. Cognitive and Physical Function in Chronic Kidney Disease. Curr Opin Nephrol Hypertens. 2014 May;23(3):291–7. Disponible en: https://doi.org/10.1097/01.mnh.0000444821.87873.7b
Tamura MK, Meier DE. Five policies to promote palliative care for patients with ESRD. Clin J Am Soc Nephrol 2013; 8: 1783–1790. Disponible en: https://doi.org/10.2215/CJN.02180213
Kurella Tamura M, O’Hare AM, Lin E, Holdsworth LM, Malcolm E, Moss AH. Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation. 2018;71(6):866–73. Disponible en: https://doi.org/10.1053/j.ajkd.2017.12.017
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
